1DpwC8F

Recommendations

Info

Child Maltreatment Title Population Recommendation Primary Care Interventions to Prevent Child Maltreatment Children and adolescents aged 0 to 18 years without signs or symptoms of maltreatment No recommendation. Grade: I (Insufficient Evidence) 68 Risk Assessment There are numerous risk factors associated with child maltreatment, including but not limited to: ●● ●● ●● ●● ●● ●● ●● ●● ●● Young, single, or nonbiological parents Parental lack of understanding of childrenís needs, child development, or parenting skills Poor parent–child relationships/negative interactions Parental thoughts or emotions that support maltreatment behaviors Family dysfunction or violence Parental history of abuse or neglect in family of origin Substance abuse within the family Social isolation, poverty, or other socioeconomic disadvantages Parental stress and distress Interventions Balance of Benefits and Harms Other Relevant USPSTF Recommendations Although the evidence is insufficient to recommend specific preventive interventions, most child maltreatment prevention programs focus on home visitation. Home visitation programs usually comprise a combination of services provided by a nurse or paraprofessional in the family’s home on a regularly scheduled basis; most programs are targeted to families with young children and often begin in the prenatal or postnatal period. The evidence on interventions in primary care to prevent child maltreatment among children without signs or symptoms of maltreatment is insufficient, and the balance of benefits and harms cannot be determined. The USPSTF has made recommendations on screening for intimate partner violence and abuse of elderly and vulnerable adults. These recommendations are available at http://www.uspreventiveservicestaskforce.org/. For a summary of the evidence systematically reviewed in making this recommendation, the full recommendation statement, and supporting documents, please go to http://www.uspreventiveservicestaskforce.org/.
Congenital Hypothyroidism Title Screening for Congenital Hypothyroidism Population All newborn infants 1 Recommendation Screen for congenital hypothyroidism. Grade: A Screening Tests Two methods of screening are used most frequently in the United States: ●● Primary TSH with backup T4. ●● Primary T4 with backup TSH. Screening for congenital hypothyroidism (CH) is mandated in all 50 states and the District of Columbia. Clinicians should become familiar with the tests used in their area and the limitations of the screening strategies employed. 69 Timing of Screening Infants should be tested between 2 and 4 days of age. Infants discharged from hospitals before 48 hours of life should be tested immediately before discharge. Specimens obtained in the first 24-48 hours of age may be falsely elevated for TSH regardless of the screening method used. Suggestions for Practice Other Relevant Recommendations from the USPSTF Infants with abnormal screens should receive confirmatory testing and begin appropriate treatment with thyroid hormone replacement within 2 weeks after birth. Children with positive confirmatory testing in whom no permanent cause of CH is found should undergo a 30-day trial of reduced or discontinued thyroid hormone replacement therapy to determine if the hypothyroidism is permanent or transient. This trial of reduced or discontinued therapy should take place at some time after the child reaches 3 years of age. Additional USPSTF recommendations regarding screening tests for newborns can be accessed at: http://www.uspreventiveservicestaskforce.org/recommendations.htm#pediatric 1 This recommendation applies to all infants born in the U.S. Premature, very low birth weight and ill infants may benefit from additional screening. These conditions are associated with decreased sensitivity and specificity of screening tests. For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement, and supporting documents, please go to http://www.uspreventiveservicestaskforce.org.
Page 1 and 2:
The Guide to Clinical Preventive Se
Page 3:
The Guide to Clinical Preventive Se
Page 7 and 8:
Preface The U.S. Preventive Service
Page 9:
Selector (ePSS), available via PDA,
Page 12 and 13:
Hemochromatosis, Screening.........
Page 15:
Preventive Services Recommended by
Page 18 and 19:
Section 1: Preventive Services Reco
Page 20 and 21:
4 13 Asymptomatic adults with susta
Page 23 and 24:
Abdominal Aortic Aneurysm Title Scr
Page 25 and 26:
Aspirin for the Prevention of Cardi
Page 27 and 28:
Bacterial Vaginosis in Pregnancy Ti
Page 29 and 30:
Bladder Cancer Title Population Rec
Page 31 and 32:
Breast Cancer (Preventive Medicatio
Page 33 and 34: Breastfeeding Title Primary Care In
Page 35 and 36: Cervical Cancer Title Screening for
Page 37 and 38: Chronic Kidney Disease Title Popula
Page 39 and 40: Cognitive Impairment Title Populati
Page 41 and 42: Coronary Heart Disease (Risk Assess
Page 43 and 44: Depression in Adults Title Populati
Page 45 and 46: Falls in Older Adults Title Populat
Page 47 and 48: Genital Herpes Time Screening for G
Page 49 and 50: Glaucoma Title Population Recommend
Page 51 and 52: Healthful Diet and Physical Activit
Page 53 and 54: Hemochromatosis Title Population Re
Page 55 and 56: Hepatitis C Virus Infection Title S
Page 57 and 58: HIV Infection Title Population Reco
Page 59 and 60: Impaired Visual Acuity in Older Adu
Page 61 and 62: Lipid Disorders in Adults Title Scr
Page 63 and 64: Menopausal Hormone Therapy Title Me
Page 65 and 66: Obesity in Adults Title Population
Page 67 and 68: Osteoporosis Title Screening for Os
Page 69 and 70: Peripheral Artery Disease Title Pop
Page 71 and 72: Sexually Transmitted Infections Tit
Page 73 and 74: Skin Cancer (Screening) Title Scree
Page 75 and 76: Syphilis (Pregnant Women) Title Pop
Page 77 and 78: Tobacco Use in Adults Title Counsel
Page 79: Vitamin Supplementation to Prevent
Page 83: Blood Lead Levels in Children and P
Page 87 and 88: Gonococcal Ophthalmia Neonatorum Ti
Page 89 and 90: High Blood Pressure (Children) Titl
Page 91 and 92: Illicit and Prescription Drug Use i
Page 93 and 94: Iron Deficiency Anemia (Supplementa
Page 95 and 96: Major Depressive Disorder in Childr
Page 97 and 98: Phenylketonuria (PKU) Title Populat
Page 99 and 100: Speech and Language Delay Title Pop
Page 101: Visual Impairment in Children Ages
Page 105: Immunizations for Adults and Childr
Page 109 and 110: Topics in Progress Each USPSTF reco
Page 111: Appendixes and Index
Page 114 and 115: Grade Definitions What the Grades M
Page 116 and 117: Grade Definitions Prior to May 2007
Page 118 and 119: David Grossman, M.D., M.P.H. Center
Page 120 and 121: Appendix C Acknowledgements AHRQ St
Page 122 and 123: Liaisons to the USPSTF Primary care
Page 124 and 125: The Task Force does not explicitly
Page 126 and 127: ■■ ■■ Access the Electronic
Page 128 and 129: Appendix E More Resources AHRQ’s
Page 130 and 131: Healthy People 2020 Healthy People
Page 133 and 134: Index 2-hour postload plasma (see D
Page 135 and 136:
Coronary Heart Disease (Risk Assess
Page 137 and 138:
*Illicit and Prescription Drug Use
Page 139:
Syphilis Infection (Pregnant Women)
Page 143 and 144:
The U.S. Preventive Services Task F
show all

1DpwC8F

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?